- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Amanda A. Sonneborn
News 22 results
Cases & Deals
May 31, 2022
CatchMark To Combine with Potlatch In $5 Billion All-Stock Transaction
In the News · Source: Corporate Counsel
In the News · Source: Crain’s Chicago Business
February 18, 2022
Amanda Sonneborn explains why the U.S. government may never mandate boosters for healthcare workers
Cases & Deals
In the News · Source: The New York Times and Verywell Health
In the News · Source: Financial Times
December 10, 2021
Amanda Sonneborn is quoted in a profile that examined the U.S. government granting vaccine mandate exceptions to 165,000 workers
In the News · Source: Yahoo! Finance
November 30, 2021
Amanda Sonneborn discusses Omicron’s impact on return-to-office policies
In the News · Source: Fortune and SHRM
In the News · Source: Capital & Main
November 8, 2021
Dixie Johnson, Amanda Sonneborn and Keith Townsend’s client alert that examined the SEC enforcement of human capital disclosures is referenced
In the News · Source: The Hill and Yahoo! Finance
November 7, 2021
Amanda Sonneborn comments on the Biden administration’s coronavirus vaccine-or-test mandate for the private sector
In the News · Source: Associated Press
November 5, 2021
Amanda Sonneborn discusses the Biden administration’s sweeping new COVID-19 mandate that will apply to 84 million workers at mid-size and large companies
In the News · Source: Global Legal Chronicle
October 6, 2021
K&S advises UPS on its acquisition of Roadie